ADC Therapeutics Income Statement (2019-2026) | ADCT

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
0.00B0.01B0.00B0.05B0.02B0.08B69.80B0.02B0.02B0.01B0.02B0.02B0.02B0.01B0.02B0.02B0.02B
Cost of Revenue (Quarter)
0.00B0.00B0.77B0.00B0.00B0.00B0.49B0.00B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Gross Profit (Quarter)
0.00B0.01B-0.77B0.05B0.02B0.08B69.31B0.02B0.00B0.00B0.01B0.01B0.01B-0.01B0.01B0.01B0.01B
Operating items
Amortization - Intangibles (Quarter)
38.0033.0033.0026.0031.0031.0030.0052.0051.0052.00
Research & Development (Quarter)
-0.04B-0.04B-0.00B-0.05B-0.05B-0.04B-0.00B-0.04B0.03B0.03B0.03B0.02B0.03B0.03B0.03B0.03B0.02B
Selling, General & Administrative (Quarter)
-0.02B-0.02B-0.00B-0.02B-0.02B-0.02B-0.00B-0.02B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Restructuring Costs (Quarter)
0.01B0.00B
Other Operating Expenses (Quarter)
-0.02B-0.02B-0.00B-0.02B-0.02B5.01B-0.00B-0.02B0.02B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.02B
Operating Expenses (Quarter)
-0.07B-0.07B-0.00B-0.09B-0.09B4.95B-0.00B-0.07B0.06B0.05B0.05B0.05B0.05B0.05B0.06B0.05B0.05B
Operating Income (Quarter)
-0.07B-0.06B-62.78B-0.04B-0.07B-0.00B-10.74B-0.05B3.02B-0.04B-0.03B-0.03B-0.04B-0.03B-0.04B-0.03B-0.03B
EBIT (Quarter)
-0.07B-0.06B-62.78B-0.04B-0.07B-0.00B-10.74B-0.05B3.02B-0.04B-0.03B-0.03B-0.04B-0.03B-0.04B-0.03B-0.03B
Non-operating items
Interest & Investment Income (Quarter)
0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Other Non Operating Income (Quarter)
-0.00B0.27B-0.01B0.00B-0.00B0.00B0.00B0.00B-0.00B0.00B0.00B
Non Operating Income (Quarter)
-0.00B-0.01B0.00B0.02B0.00B-0.05B-0.00B-0.01B-0.01B0.00B-0.01B0.00B0.00B0.00B-0.00B0.00B-0.01B
Net income details
EBT (Quarter)
-0.07B-0.07B-0.00B-0.02B-0.07B-0.05B-0.00B-0.06B-0.05B-0.05B-0.05B-0.04B-0.04B-0.04B-0.06B-0.04B-0.03B
Tax Provisions (Quarter)
-0.00B-0.00B0.00B0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B0.00B0.00B0.00B0.00B
Profit After Tax (Quarter)
-0.07B0.00B-0.00B-0.02B3.91B4.35B-0.00B-0.06B-0.05B-0.05B-0.09B-0.05B-0.04B-0.04B-0.03B-0.04B-0.06B-0.04B-0.01B-0.03B
Equity Income (Quarter)
-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B
Income from Continuing Operations (Quarter)
-0.07B-0.07B-0.00B-0.02B-0.07B-0.05B-0.00B-0.06B-0.05B-0.05B-0.05B-0.04B-0.04B-0.04B-0.06B-0.04B-0.03B
Consolidated Net Income (Quarter)
-0.07B-0.07B-0.00B-0.02B-0.07B-0.05B-0.00B-0.06B-0.05B-0.05B-0.05B-0.04B-0.04B-0.04B-0.06B-0.04B-0.03B
Income towards Parent Company (Quarter)
0.07B0.07B-0.00B0.02B0.06B0.05B-0.00B-0.00B-0.00B-0.00B-0.05B-0.04B-0.04B-0.04B-0.06B-0.04B-0.03B
Net Income towards Common Stockholders (Quarter)
0.07B0.07B-0.00B0.02B0.06B0.05B-0.00B-0.00B-0.00B-0.00B-0.05B-0.04B-0.04B-0.04B-0.06B-0.04B-0.03B
Additional items
EPS (Basic) (Quarter)
0.00B0.00B0.000.00B0.00B0.00B0.00-0.01-0.60-0.57-0.56-0.38-0.42-0.36-0.50-0.30-0.21
EPS (Weighted Average and Diluted) (Quarter)
0.00B0.00B0.00B0.00B0.00B-80.31-0.60-0.57-0.56-0.38-0.42-0.36-0.50-0.30-0.21
Shares Outstanding (Weighted Average) (Quarter)
0.00B0.00B0.08B220.000.00B0.00B0.08B0.01B0.08B0.00B0.08B0.08B0.09B0.09B0.10B0.11B0.11B0.14B0.13B0.15B
Shares Outstanding (Diluted Average) (Quarter)
0.00B0.00B220.000.00B0.00B740.000.00B0.00B0.08B0.09B0.10B0.11B0.11B0.14B0.15B
EBITDA (Quarter)
-0.07B-0.06B-62.78B-0.04B-0.07B-0.00B4.35B-0.06B2.47B2.72B-0.05B-0.03B-0.04B-0.03B-0.04B-0.03B-0.03B
Interest Expenses (Quarter)
0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B0.01B
Tax Rate (Quarter)
0.33%0.20%-911.20%-6.56%-1.45%-1.39%19.65%-0.44%8.55%0.19%-0.44%-0.66%-0.21%-0.43%-2.26%